|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Net income (loss) | |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |
| Interest income earned in trust account | |
| Changes in operating assets and liabilities: | |
| Decrease (Increase) in prepaid expenses | |
| Increase in accrued expenses | |
| Net cash used in operating activities | |
| Cash flows from investing activities | |
| Cash deposited in trust account | |
| Net cash used in investing activities | |
| Cash flows from financing activities | |
| Proceeds from issuance of ordinary shares | |
| Proceeds from promissory note payable to related party | |
| Proceeds from issuance of public units | |
| Proceeds from issuance of private units | |
| Payment of underwriting fee | |
| Payment of offering costs | |
| Repayment of the principal of promissory note to related party | |
| Net cash provided by financing activities | |
| Net increase in cash | |
| Cash at beginning of period | |
| Cash at end of period | |
| Non-cash financing activities | |
| Deferred underwriting commission charged to additional paid in capital | |
| Initial value of public shares subject to possible redemption | |
| Allocation of offering cost related to public shares subject to possible redemption | |
| Increases of carrying value of redeemable public shares |
Loading...
